Zobrazeno 1 - 10
of 499
pro vyhledávání: ''
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Autor:
Erik Van Limbergen, Bülent Polat, Jocelyn Gal, Gilles Houvenaeghel, Jean-Michel Hannoun-Levi, Benjamin Guix, Cristina Gutierrez, Marie-Eve Chand, Vratislav Strnad, Renaud Schiappa, Csaba Polgár, Aurélie Belliere-Calandry, K. Loessl, Daniela Kauer-Domer, Razvan Galalae, David Pasquier, Séverine Racadot, Claire Lemanski, Viktor Smanykó
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 110:452-461
Purpose Second conservative treatment has emerged as an option for patients with a second ipsilateral breast tumor event after conserving surgery and breast irradiation. We aimed to address the lack of evidence regarding second breast event treatment
Autor:
Loretta Erhunmwunsee, Scott Glaser, Richard Li, Ashwin Shinde, Erminia Massarelli, Arya Amini, Philip H.G. Ituarte, Jessica Vazquez, Kimlin Tam Ashing, Ravi Salgia, Brittney Chau
Publikováno v:
Cancer Medicine, Vol 10, Iss 8, Pp 2660-2667 (2021)
Cancer Medicine
Cancer Medicine
Objective The purpose of this study was to evaluate overall survival (OS) outcomes by race, stratified by country of origin in patients diagnosed with NSCLC in California. Methods We performed a retrospective analysis of nonsmall cell lung cancer (NS
Publikováno v:
Cancer Medicine, Vol 10, Iss 3, Pp 974-988 (2021)
Cancer Medicine
Cancer Medicine
Background Metastatic adenocarcinoma of unknown primary site (MACUP) is the most common cancer of unknown primary site, and shows worse prognosis. Prediction of its tumor site origin attracts a growing attention. However, the site determined by gene
Autor:
Justin T. Moyers, Hsin Hsiang Clarence Tsai, Jiahao Peng, David Shavlik, Daniel Sufficool, Esther G. Chong, Gayathri Nagaraj
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 4, Pp 1201-1211 (2021)
Cancer Medicine, Vol 10, Iss 4, Pp 1201-1211 (2021)
Introduction Immunotherapy (IT) and radiotherapy (RT) have improved overall survival in patients with melanoma with brain metastasis (MBM). We examined the real‐world survival impact of IT and RT combination and timing strategies. Materials and Met
Autor:
John Barnard, Najla Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Eric Padron, Guillermo Garcia-Manero, Alan F. List, Gail J. Roboz, Rami S. Komrokji, David P. Steensma, David A. Sallman
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 447-453 (2021)
Cancer Medicine
Cancer Medicine
The utility of the International Working Group (IWG) 2006 response criteria for myelodysplastic syndromes (MDS) as a surrogate endpoint for outcomes is unclear. We assessed the validity of the IWG 2006 response criteria in a large cohort of higher‐
Autor:
Chien-Yu Lin, Ching-Hsin Lee, Yung-Chih Chou, Tsung-Ying Ho, Y.Y. Wu, Pei-Rung Chen, Kai-Ping Chang, S.P. Hung, Ngan-Ming Tsang, Wen-Chi Chou, Chia-Hsin Lin, Joseph Tung-Chieh Chang, Chun-Chieh Wang, Bing-Shen Huang, Po-Jui Chen, Kang-Hsing Fan
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 649-658 (2021)
Cancer Medicine
Cancer Medicine
Objectives To investigate the prognostic value of the preoperative systemic immune‐inflammation index (SII) in patients with oral cavity squamous cell carcinoma (OC‐SCC) treated with curative surgery followed by adjuvant radiotherapy (RT) or chem
Autor:
Jian-Jun Qian, Chi Zhang, Bing-Bing Su, Bing Yan, Dou-Sheng Bai, Sheng-Jie Jin, Guo-Qing Jiang
Publikováno v:
Cancer Medicine, Vol 10, Iss 2, Pp 496-506 (2021)
Cancer Medicine
Cancer Medicine
Background Our purpose was to establish and validate a nomogram model in early hepatocellular carcinoma (HCC) patients for predicting the cancer‐specific survival (CSS). Methods We extracted eligible data of relevant patients between 2010 and 2015
Autor:
Samantha LoRusso, Qiuhong Zhao, Jason Prosek, Katherine Pfund, Srinivas Devarakonda, Ashley E. Rosko, Patrick Elder, Elyse Redder, Ajay Vallakati, Jordan Bittengle, Yvonne A. Efebera, Courtney M. Campbell, Maria Chaudhry, Salem Almaani, Nidhi Sharma, Samir V. Parikh, Naresh Bumma, Don M. Benson, Abdullah Khan, Rami Kahwash, Nita Williams, Miriam Freimer, Michael Ozga
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Cancer Medicine, Vol 10, Iss 3, Pp 965-973 (2021)
Background Systemic light chain (AL) amyloidosis is a clonal plasma‐cell neoplasm that carries a poor prognosis. Although AL amyloidosis and Multiple Myeloma (MM) can co‐exist and share various cytogenetic chromosomal abnormalities, little is kno
Autor:
Zachary William Neil Veitch, Esmail Mutahar Al-Ezzi, Jay S. Wunder, Anthony M Griffin, Peter C. Ferguson, Abha A. Gupta, Samir Fasih, Albiruni Ryan Abdul Razak
Publikováno v:
Cancer Medicine
Non‐osteogenic, non‐Ewing soft‐tissue sarcoma (NONE‐STS) of bone is a rare presentation of primary bone cancers. Optimal treatments and outcomes for this heterogenous group are poorly described. We evaluated the factors associated with long